MicroRNAs (miRNAs) have been reported to serve as silencers to repress gene 38 expression at post-transcriptional level. Multiple miRNAs have been demonstrated to 39 play important roles in osteogenesis. MiR-378, a conserved miRNA, was reported to 40 mediate bone metabolism and influence bone development, but the detailed function 41 and underlying mechanism remain obscure. In this study, the miR-378 transgenic (TG) 42 mouse was developed to study the role of miR-378 in osteogenic differentiation as 43 well as bone formation. The abnormal bone tissues and impaired bone quality were 44 displayed in the miR-378 TG mice, and a delayed healing effect was observed during 45 bone fracture of the miR-378 TG mice. The osteogenic differentiation of MSCs 46 derived from this TG mouse was also inhibited. We also found that miR-378 mimics 47 suppressed while anti-miR-378 promoted osteogenesis of human MSCs. Two Wnt 48 family members Wnt6 and Wnt10a were identified as bona fide targets of miR-378, 49 and their expression were decreased by this miRNA, which eventually induced the 50 inactivation of Wnt/β-catenin signaling. Finally, the sh-miR-378 modified MSCs were 51 locally injected into the fracture sites in an established mouse fracture model. The 52 results indicated that miR-378 inhibitor therapy could promote bone formation and 53 stimulate healing process in vivo. In conclude, miR-378 suppressed osteogenesis and 54 bone formation via inactivating Wnt/β-catenin signaling, suggesting miR-378 may be 55 a potential therapeutic target for bone diseases.
Introduction
Therefore, the function of miR-378 in osteogenesis remains intriguing. 82 In this study, abnormal bone tissues and impaired bone quality were exhibited in the 83 miR-378 transgenic (TG) mice; and a delayed bone formation and fracture healing 84 was also found in this TG mice. Moreover, we found that miR-378 overexpression 85 suppressed while its antagonists promoted osteogenic differentiation, suggesting 86 miR-378 may play a significant role in osteoblast differentiation and bone 87 regeneration. Furthermore, two Wnt family members Wnt6 and Wnt10a were 88 identified as targets of miR-378, and their expression were decreased by miR-378, 89 which eventually suppressed Wnt/β-catenin signaling. Therefore, miR-378 inhibited 90 osteoblast differentiation and impaired bone formation, suggesting that it may be a 91 potential therapeutic target for bone diseases. To investigate the function of miR-378 in bone formation, we compared the bone 97 tissues from miR-378 TG mice and that from their wild-type (WT) mice. By digital 98 radiography examination, the bone size and length of the femur ( Figure 1A Figure 1D for front view and Supplementary Figure 1E for side view) were all the bone remodeling was more vigorously compared with TG group (Figure 2E ). 127 Moreover, by immunohistochemistry staining, the decreased OCN and OPN 128 expression were also observed in miR-378 group, suggesting an impaired effect of 129 miR-378 on bone formation and remodeling ( Figure 2E ). with that from WT group at day 3 ( Figure 3A ). And the TG group had fewer 136 mineralized nodules compared to that of the WT group at day 14 ( Figure 3B ).
137
Furthermore, the expression of osteogenic marker genes including Runt-related 138 transcription factor 2 (Runx2), ALP, osteocalcin (OCN), osteopontin (OPN), 139 osteoprotegerin (OPG), bone morphogenetic protein 2 (BMP2) and osterix (Osx) were 140 significantly repressed in the TG group at day 7 ( Figure 3C ).
141
To further identify the function of miR-378 in osteoblast differentiation, miR-378 142 mimics and antagonist were also introduced into human bone marrow MSCs under 143 osteogenic inductive condition. ALP activities were suppressed by miR-378-3p and 144 miR-378-5p mimics at day 3 ( Figure 3D ). And fewer calcium nodules were observed 145 in miR-378-3p and miR-378-5p groups at day 14 ( Figure 3E ). The expression of 146 osteogenic marker genes including Runx2, ALP, OCN, BMP2, OPN and Osx were 147 significantly suppressed by miR-378-3p and miR-378-5p mimics ( Figure 3F ). On the other hand, when the antagonists of miR-378-5p and miR-378-3p were introduced, 149 the ALP activity ( Figure 3G ), mineralized nodules ( Figure 3H ) and the osteogenic 150 marker genes expression ( Figure 3I ) were obviously increased. All these data 151 demonstrate that miR-378 may directly regulate the osteogenesis of MSCs, thereby 152 affecting bone development.
153
Wnt6 and Wnt10a were real targets for miR-378 in MSCs 154 MiRNAs function as regulators in multiple biological activities through directly 155 targeting protein-coding genes. In terms of the suppressive effect of miR-378 on 156 osteogenesis, we tried to characterize the candidate target genes of this miRNA.
157
Among the candidates predicted by bioinformatics analyses, the Wnt family members 158 Wnt6 and Wnt10a were found to be the most promising candidates for miR-378-3p 159 and miR-378-5p, respectively. Their predicted binding sites were shown in Figure 4A 160 and Figure 4C . To validate their direct interaction, the binding and mutated sites into 161 the 3'UTR of Wnt6 and Wnt10a were inserted into the pmiR-GLO vector to generate 162 the luciferase reporter vectors. Co-transfection of miR-378 isoforms with the two 163 luciferase reporters was performed, and it was showed that miR-378-5p and 164 miR-378-3p dramatically suppressed the luciferase activity of these luciferase 165 reporters of Wnt6 and Wnt10a and mutations on their binding sites successfully 166 abolished the suppressive effects ( Figure 4B and Figure 4D ). With miR-378-3p and 167 miR-378-5p transfection, the expression of Wnt10a and Wnt6 were both significantly 168 reduced in human BMSCs at the mRNA and protein levels ( Figure 4E and Figure 4G ). Figure 6F ). All these data suggest that Wnt/β-catenin signaling could be involved in Figure 4E) . Under the 251 osteogenic inductive conditions, MSCs derived from miR-378 TG mice showed weak 252 potential of osteogenic differentiation compared with that from WT mice.
253
Furthermore, we also found that miR-378 mimics suppressed while their inhibitors 254 could promote osteogenic differentiation of human MSCs. All these provide strong 255 support for the impaired bone formation in miR-378 TG mice. Consistent with our 256 study, miR-378 inhibited osteogenesis of mouse osteoblast cell line MC3T3-E1 257 cells. 10 miR-378 secreted by osteoclast was also discovered to be increased in 258 exosomes of patients with bone metastases compared to healthy controls and the 259 expression level was correlated with bone metastasis burden. 19 Based on the previous 260 reports and our results, miR-378 may be a negative regulator of osteogenesis and bone 261 regeneration.
262
As for the molecular mechanism of miR-378, it has been reported that miR-378 263 mediated metabolic homeostasis in skeletal muscle via Akt1/FoxO1/PEPCK pathway.
264
IGF1R signaling pathway was also reported to be involved in miR-378 mediated group. Furthermore, more vigorous bone formation and bone remodeling was 297 observed in sh-miR-378 group by histological analyses. Therefore, these results 298 suggest an accelerated effect of sh-miR-378 on fracture healing in vivo. 299 In summary, our data demonstrated that miR-378 could impair the bone formation in 300 vivo and suppress the osteogenesis in vitro. Two Wnt family members, Wnt6 and 301 Wnt10a, were identified as novel targets of this miRNA. MiR-378 led to the 302 repression of the two targets, which eventually inactivated Wnt/β-catenin pathway and hence suppressed osteogenesis. Therefore, mR-378 may be a potential novel 304 therapeutic target, and the knowledge gained from this study will provide insight for 305 developing a new cell therapy strategy to bone diseases. Mouse or human MSCs were seeded in 24 well plates at a density of 2× 10 5 cells per 342 well and osteogenic differentiation was induced when cells reach 80% confluence.
343
For the alizarin red S staining, the mouse or human MSCs were washed with PBS and 344 fixed with 70% ethanol for 30 min. The MSCs were then stained with 2% alizarin red 345 S staining solution for 10 min. The stained calcified nodules were scanned using 346 Epson launches Perfection V850 (Seiko Epson, Japan). The ALP activity was 347 measured and analyzed following the published protocol. 6 Sh-miR-378 mediated mouse MSCs were generated using lentivirus-mediated gene 350 delivery system as previously described. 6 And the supernatant medium containing method.
369
Western blot analysis 370 Total protein of harvested cell were lysed using RIPA buffer (25 mM Tris-Cl, pH 8.0, 371 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40) supplemented 372 with complete mini protease inhibitor cocktail (Roche, USA) and the soluble protein 373 was collected by centrifuge at 14,000 rpm for 10 min at 4°C. Soluble protein fractures 374 were then mixed with 5x sample loading buffer (Roche, USA) and boiled for 5 min.
375
To perform Western blotting analysis, the protein samples were subjected to 376 SDS-PAGE gel and electrophoresed at 120V for 2h. After that, the protein from 377 SDS-PAGE gel was electroblotted onto a PVDF membrane at 100 V for 1 h at 4°C.
378
The membranes were then blocked with 5% non-fat milk and probed with the 379 following antibodies: β-catenin (1: 3,000, BD Biosciences, USA), Wnt6 (1: 1,000, 380 Sigma, USA), Wnt10a (1: 1,000) and β-actin (1: 4,000, Sigma, USA). The results 381 were visualized on the X-Ray film by Kodak film developer (Fujifilm, Japan).
382
Luciferase assay 383 Dual-luciferase assay was performed according to the instructions of dual-luciferase 384 assay reagent (Promega, USA) with some modifications. Briefly, HEK293 cells were 385 seeded in 24-well plate, and the cells were allowed to grow until 80% confluence. For bone fracture healing capacity comparison of WT and miR-378 TG mouse, 10 396 male mice of each type at the age of three month was used. For therapeutic effect of 397 sh-miR-378 lentivirus-infected MSC on bone fracture healing, 20 of miR-378 TG 398 mice at the age of three months were applied. Generally speaking, the mice were 399 carried under general anesthesia and sterilizing procedures. A lateral incision was 400 made through shaved skin from right lateral knee to the greater trochanter, the 401 osteotomy was made by a hand saw at the middle site of right femur, then a hole was 402 drilled at the intercondylar notch by inserting a 23-gauge needle (BD Biosciences, 403 USA) into the bone marrow cavity to fix the fracture. The incision was closed and the 404 fracture was confirmed by X-radiography. For sh-miR-378 treatment study, 20 of 405 miR-378 TG mice were equally and randomly assigned into 2 groups after surgery: 406 sh-NC group and sh-miR-378 group. The mouse MSCs were harvested by 0.25% 407 trypsin and re-suspended in PBS. A total of 5x 10 5 cells resuspended in 20µl PBS 408 were locally injected into the fracture site of bone under anesthesia using a Hamilton 409 syringe (Hamilton, USA) and a 30-gauge 1/2 needle (BD Biosciences, USA). X-rays 410 were taken weekly using a digital X-ray machine (Faxitron X-Ray Corp., USA) to 411 evaluate the fracture healing condition. Each mouse was exposure for 6000 ms and at 412 voltage of 32 kV. Four weeks post surgery, the mice were sacrificed and the femurs 413 were collected for analysis. 415 The structure differences of mouse femur and tibia, as well as the structural change on 416 the fracture sites were quantitatively assessed using μCT as previously described. 32
Micro-computed tomography (μCT)

417
Mice femur and tibia samples were excised and the muscles and soft tissues were 418 carefully removed. All the specimens were imaged using a high-solution μCT40 419 (Scanco Medical, Switzerland) with a voltage of 70kV and a current of 114μA and 420 10.5μm isotropic resolution. The gray-scale images were segmented with a low-pass 421 filter (sigma=1.2, support=2) to suppress noise and a fixed threshold to perform three 422 dimensional (3D) reconstruction of the mineralized bone phase. Reconstruction of
